This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
The Dow Jones uses price weighting, which gives more influence to higher-priced stocks. This note covers the rationale and implications for investors.
25,369 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
After a quarterly report, Netflix's post-earnings sell-off just highlighted a shift in strategy. This article breaks ...
Investors often chase growth or income. When Enbridge trades under $60, a thoughtful plan can unlock both. This guide...
Ripple's private business shows strong growth while XRP trades near a $1 price. This article builds a practical, evid...
Nvidia sits at the center of AI-driven growth. This guide examines potential price paths for what will nvidia stock's...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
A big investor just bought millions of Grindr shares after the stock plunged. This article breaks down why grindr sto...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...